GSK (LSE: GSK) has settled 93% of Zantac (ranitidine) product liability cases in the USA, agreeing to pay up to $2.2 billion ...

Johnson & Johnson’s Tecvayli (teclistamab) has been recommended by NICE as a first-line treatment for myeloma in England and ...

Nanoscope Therapeutics says that, following a productive FDA meeting with the US Food and Drug Administration (FDA) for its ...

Insitro has signed three strategic agreements with Eli Lilly aimed at advancing treatments for metabolic diseases like MASLD, ...

The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Applications for AVT03, a proposed ...

US pharma giant Pfizer today released positive top line results from the final prespecified overall survival (OS) analysis of ...

The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for Part 1 of the New Drug Application ...

China's Quantum Pharmaceuticals has announced a major licensing deal between its subsidiary Ailux Biologics and Johnson & ...

Gene therapy start-up GEMMA Biotherapeutics has partnered with Brazil's Fiocruz in a deal worth up to $100 million, aiming to ...

Black Diamond Therapeutics (Nasdaq: BDTX) is restructuring to focus on its lead drug, BDTX-1535, aimed at non-small cell lung ...

Beijing’s InnoCare Pharma has announced promising Phase II results for its TYK2 inhibitor, ICP-488, in moderate-to-severe ...

Yesterday, the US Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), ...